FREE ELECTRONIC LIBRARY - Dissertations, online materials

Pages:   || 2 | 3 | 4 |

«• HIGHLIGHTS OF PRESCRIBING INFORMATION Behavioral and mood disturbances: May Include euphoria, insomnia, mood These highlights do not include all ...»

-- [ Page 1 ] --

HIGHLIGHTS OF PRESCRIBING INFORMATION Behavioral and mood disturbances: May Include euphoria, insomnia, mood

These highlights do not include all the information needed to use Flo-Pred swings, personality changes, severe depression, and psychosis. Existing

safely and effectively. See full prescribing information for Flo-Pred. conditions may be aggravated. (5.5)

• Decreases in bone density: Monitor bone density in patients receiving long- Flo-Pred (prednisolone acetate) Suspension for Oral use term corticosteroid therapy. (5.6) Initial U.S. Approval: 1955

• Ophthalmic effects: May include cataracts, infections and glaucoma.

Monitor intraocular pressure if corticosteroid therapy is continued for more

-------------------------------INDICATIONS AND USAGE------------------------------ than 6 weeks.(5.7) Flo-Pred is a corticosteroid indicated •

• as an anti-inflammatory or immunosuppressive agent for certain allergic, Live or live attenuated vaccines: Do not administer to patients receiving immunosuppressive doses of corticosteroids. (5.8) dermatologic, gastrointestinal, hematologic, ophthalmologic, nervous system, • renal, respiratory, rheumatologic, specific infectious diseases or conditions and Negative effects on growth and development: Monitor pediatric patients on organ transplantation (1) long-term corticosteroid therapy. (5.9)

• for the treatment of certain endocrine conditions (1) • Use in pregnancy: Fetal harm can occur with first trimester use. Apprise

• for palliation of certain neoplastic conditions (1) women of potential harm to the fetus. (5.10)

-------------------------DOSAGE AND ADMINISTRATION------------------------ --------------------------ADVERSE REACTIONS----------------------------- Individualize dosing based on disease severity and

–  –  –

Reference ID: 2960745



Flo-Pred (prednisolone acetate oral suspension) is indicated in the treatment of the following diseases or conditions:

1.1 Allergic Conditions

Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in adults and pediatric populations with:

–  –  –

1.3 Endocrine Conditions • Congenital adrenal hyperplasia • Hypercalcemia of malignancy • Nonsuppurative thyroiditis • Primary or secondary adrenocortical insufficiency: hydrocortisone or cortisone is the first choice: synthetic analogs may be used in conjunction with mineralocorticoids where applicable

1.4 Gastrointestinal Diseases

During acute episodes in:

–  –  –

1.7 Nervous System Conditions • Acute exacerbations of multiple sclerosis • Cerebral edema associated with primary or metastatic brain tumor, craniotomy or head injury

1.8 Ophthalmic Conditions Reference ID: 2960745 • Sympathetic ophthalmia • Uveitis and ocular inflammatory conditions unresponsive to topical steroids

1.9 Conditions Related to Organ Transplantation

–  –  –

1.10 Pulmonary Diseases • Acute exacerbations of chronic obstructive pulmonary disease (COPD) • Allergic bronchopulmonary aspergillosis • Aspiration pneumonitis • Asthma • Fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate chemotherapy • Hypersensitivity pneumonitis • Idiopathic bronchiolitis obliterans with organizing pneumonia • Idiopathic eosinophilic pneumonias • Idiopathic pulmonary fibrosis • Pneumocystis carinii pneumonia (PCP) associated with hypoxemia occurring in an HIV(+) individual who is also under treatment with appropriate anti-PCP antibiotics.

• Symptomatic sarcoidosis

1.11 Renal Conditions • To induce a diuresis or remission of proteinuria in nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus

1.12 Rheumatologic Conditions

As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in:

–  –  –

1.13 Specific Infectious Diseases • Trichinosis with neurologic or myocardial involvement.

• Tuberculous meningitis with subarachnoid block or impending block used concurrently with appropriate antituberculous chemotherapy.


2.1 Recommended Dosing Dosage of Flo-Pred should be individualized according to the severity of the disease and the response of the patient. For pediatric patients, the recommended dosage should be governed by the same considerations rather than strict adherence to the ratio indicated by age or body weight.

The initial dosage of Flo-Pred may vary from 5 mg to 60 mg per day depending on the specific disease entity being treated. In situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period there is a lack of satisfactory clinical response, Flo-Pred should be discontinued and the patient transferred to other appropriate therapy. It should be emphasized that dosage requirements are variable and must be individualized on the basis of the disease under treatment and the response of the patient.

Reference ID: 2960745 After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached. It should be kept in mind that constant monitoring is needed in regard to drug dosage. Included in the situations which may make dosage adjustments necessary are changes in clinical status secondary to remissions or exacerbations in the disease process, the patient's individual drug responsiveness, and the effect of patient exposure to stressful situations not directly related to the disease entity under treatment. In this latter situation it may be necessary to increase the dosage of Flo-Pred for a period of time consistent with the patient's condition. If a period of spontaneous remission occurs in a chronic condition, treatment should be discontinued. If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly.

Multiple sclerosis In the treatment of acute exacerbations of multiple sclerosis, daily doses of 200 mg of prednisolone for a week followed by 80 mg every other day for one month have been shown to be effective.

Pediatric The range of initial doses is 0.14 to 2 mg/kg/day in three or four divided doses (4 to 60 mg/m2/day).

Nephrotic syndrome The standard regimen used to treat nephrotic syndrome in pediatric patients is 60 mg/m2/day given in three divided doses for 4 weeks, followed by 4 weeks of single dose alternate-day therapy at 40 mg/m2/day.

–  –  –

The National Heart, Lung, and Blood Institute (NHLBI) recommended dosing for systemic prednisone, prednisolone or methylprednisolone in children whose asthma is uncontrolled by inhaled corticosteroids and long-acting bronchodilators is 1-2 mg/kg/day in single or divided doses.

It is further recommended that short course, or "burst" therapy, be continued until a child achieves a peak expiratory flow rate of 80% of his or her personal best or symptoms resolve. This usually requires 3 to 10 days of treatment, although it can take longer. There is no evidence that tapering the dose after improvement will prevent a relapse.

2.2 Recommended Monitoring

Blood pressure, body weight, routine laboratory studies, including two-hour postprandial blood glucose and serum potassium, and a chest X-ray should be obtained at regular intervals during prolonged therapy. Upper GI X-rays are desirable in patients with known or suspected peptic ulcer disease.

2.3 Corticosteroid Comparison Chart

For the purpose of comparison, the following is the equivalent milligram dosage of the various glucocorticoids:

–  –  –

These dose relationships apply only to oral or intravenous administration of these compounds. When these substances or their derivatives are injected intramuscularly or into joint spaces, their relative properties may be greatly altered.


Oral Suspension:

–  –  –


Flo-Pred is contraindicated in patients who are hypersensitive to corticosteroids such as prednisolone, or any components of this product. Rare instances of anaphylactoid reactions have occurred in patients receiving corticosteroid therapy.

Reference ID: 2960745


5.1 Alterations in Endocrine Function Hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome, and hyperglycemia. Monitor patients for these conditions with chronic use.

Corticosteroids can produce reversible HPA axis suppression with the potential for glucocorticosteroid insufficiency after withdrawal of treatment. Drug induced secondary adrenocortical insufficiency may be minimized by gradual reduction of dosage. This type of relative insufficiency may persist for months after discontinuation of therapy; therefore, in any situation of stress occurring during that period, hormone therapy should be reinstituted.

Since mineralocorticoid secretion may be impaired, salt and/or a mineralocorticoid should be administered concurrently. Mineralocorticoid supplementation is of particular importance in infancy.

Metabolic clearance of corticosteroids is decreased in hypothyroid patients and increased in hyperthyroid patients. Changes in thyroid status of the patient may necessitate adjustment in dosage.

5.2 Increased Risks Related to Infections Corticosteroids may increase the risks related to infections with any pathogen, including viral, bacterial, fungal, protozoan, or helminthic infections. The degree to which the dose, route and duration of corticosteroid administration correlates with the specific risks of infection is not well characterized, however, with increasing doses of corticosteroids, the rate of occurrence of infectious complications increases.

Corticosteroids may mask some signs of infection and may reduce resistance to new infections.

Corticosteroids may exacerbate infections and increase risk of disseminated infection.

The use of Flo-Pred in active tuberculosis should be restricted to those cases of fulminating or disseminated tuberculosis in which the corticosteroid is used for the management of the disease in conjunction with an appropriate antituberculous regimen.

Chickenpox and measles can have a more serious or even fatal course in non-immune children or adults on corticosteroids. In children or adults who have not had these diseases, particular care should be taken to avoid exposure. If a patient is exposed to chickenpox, prophylaxis with varicella zoster immune globulin (VZIG) may be indicated. If patient is exposed to measles, prophylaxis with pooled intramuscular immunoglobulin (IG) may be indicated. If chickenpox develops, treatment with antiviral agents may be considered.

Corticosteroids should be used with great care in patients with known or suspected Strongyloides (threadworm) infestation. In such patients, corticosteroid-induced immunosuppression may lead to Strongyloides hyperinfection and dissemination with widespread larval migration, often accompanied by severe enterocolitis and potentially fatal gram-negative septicemia.

Corticosteroids may exacerbate systemic fungal infections and therefore should not be used in the presence of such infections unless they are needed to control drug reactions.

Corticosteroids may increase risk of reactivation or exacerbation of latent infection.

If corticosteroids are indicated in patients with latent tuberculosis or tuberculin reactivity, close observation is necessary as reactivation of the disease may occur.

During prolonged corticosteroid therapy, these patients should receive chemoprophylaxis.

Corticosteroids may activate latent amebiasis. Therefore, it is recommended that latent or active amebiasis be ruled out before initiating corticosteroid therapy in any patient who has spent time in the tropics or in any patient with unexplained diarrhea.

Corticosteroids should not be used in cerebral malaria.

5.3 Alterations in Cardiovascular/Renal Function Corticosteroids can cause elevation of blood pressure, salt and water retention, and increased excretion of potassium and calcium. These effects are less likely to occur with the synthetic derivatives except when used in large doses. Dietary salt restriction and potassium supplementation may be necessary. These agents should be used with caution in patients with hypertension, congestive heart failure, or renal insufficiency.

Literature reports suggest an association between use of corticosteroids and left ventricular free wall rupture after a recent myocardial infarction; therefore, therapy with corticosteroids should be used with caution in these patients.

5.4 Use in Patients with Gastrointestinal Disorders There is an increased risk of gastrointestinal perforation in patients with certain GI disorders. Signs of GI perforation, such as peritoneal irritation, may be masked in patients receiving corticosteroids.

Corticosteroids should be used with caution if there is a probability of impending perforation, abscess or other pyogenic infections; diverticulitis; fresh intestinal anastomoses; and active or latent peptic ulcer.

Reference ID: 2960745

5.5 Behavioral and Mood Disturbances Corticosteroid use may be associated with central nervous system effects ranging from euphoria, insomnia, mood swings, personality changes, and severe depression, to frank psychotic manifestations. Also, existing emotional instability or psychotic tendencies may be aggravated by corticosteroids.

Pages:   || 2 | 3 | 4 |

Similar works:

«Seeing Your First Child with PANDAS/PANS Margo Thienemann, MD and The PANDAS Physicians Network Diagnostics and Therapeutics Committee Seeing Your First Child with PANDAS/PANS I. What Is PANS? The term Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) describes the clinical presentation of a subset of pediatric onset Obsessive-Compulsive Disorder (OCD). PANS may also be a subset of Avoidant/Restrictive Food Intake Disorder (ARFID). While the criteria for diagnosing PANS do not specify a...»

«Tiedemann, K. B., D. F. Ventura and C. Ades. 1986. Spectral sensitivities of the eyes of the orb we b spider Argiope argentata (Fabricius). J. Arachnol., 14 :71-78. SPECTRAL SENSITIVITIES OF THE EYES OF THE ORB WE B SPIDER ARGIOPE ARGENTATA (FABRICIUS ) Klaus B. Tiedemann, Dora Fix Ventura and Cesar Ade s Department of Experimental Psychology Institute of Psychology University of Sao Paul o Sao Paulo, Brazil ABSTRACT Spectral sensitivity curves to light between 425 and 650 nm for the...»

«The Three Symbolic Supports of the Dharma: Teaching on the Benefits of Constructing Statues and Stupas A Teaching by Khenchen Tsewang Gyatso Rinpoche Given at Orgyen Dorje Den (circa 1992) Orgyen Dorje Den, 2244 Santa Clara Ave Alameda, CA 94501 Table of Contents The Three Symbolic Supports of the Dharma: Opening Comments: The Importance of Motivation The Benefits in Four Parts Part 1 The General Benefits of Building the Three Supports Part 2 The Benefit of Building Buddha Statues: The Supports...»

«*** Free EBOOK*** Your Journey of Personal Transformation Begins HERE: An Introduction to Understanding Your Human Design Chart by Evelyn Levenson, MBA Certified Human Design Specialist Your Success By Design Coach Your Journey Begins HERE www.HumanDesignforSuccess.com This Report is for your personal use. You MAY SHARE it, in its entirety with all author and contact information. However, You May NOT Trade, Sell or Resell This Intellectual Property in Any Way. You may not reprint any part of it...»

«Begin Reading Table of Contents Copyright Page In accordance with the U.S. Copyright Act of 1976, the scanning, uploading, and electronic sharing of any part of this book without the permission of the publisher constitute unlawful piracy and theft of the author’s intellectual property. If you would like to use material from the book (other than for review purposes), prior written permission must be obtained by contacting the publisher at permissions@hbgusa.com. Thank you for your support of...»

«Louisiana Architecture: 1945-1965 The Contemporary House NATIONAL BACKGROUND Introduction: “I am not going to sit on furniture that continually reminds me of a machine shop or a hospital operating room.” Albert Einstein Machined modernism in art and architecture wasn’t for everyone. If Einstein had been talking about houses, he might have had in mind the high-art Farnsworth House near Chicago, a serene steel and glass box designed by the supreme modernist Mies van der Rohe (Photo 1). But...»

«Psychological Explanation, Ontological Commitment, and the Semantic view of Theories Colin Klein 1 Introduction Naturalistic philosophers of mind must assume some philosophy of science. For naturalism demands that we look to psychology—but to be guided by psychological theories, one must have some story about what theories are and how they work. In this way, philosophy of mind was subtly guided by philosophy of science. For the past forty years, mainstream philosophy of mind has implicitly...»

«General-purpose localization of textured • • Image regions Rutb Rosenboltz· XeroxPARC 3333 Coyote Hill Rd. Palo Alto, CA 94304 Abstract We suggest a working definition of texture: Texture is stuff that is more compactly represented by its statistics than by specifying the configuration of its parts. This definition suggests that to fmd texture we look for outliers to the local statistics, and label as texture the regions with no outliers. We present a method, based upon this idea, for...»

«1 Pierrette Meisch, criminologue, Baptiste Antoine, licencié en licenciée en santé publique, formée sciences psychologiques, formé en en approche familiale systémique et médiation, Centre de Consultation et en médiation, directrice à la de Médiation Familiale de la Fondation Pro Familia Fondation Pro Familia Fondation Pro Familia A la recherche des significations des violences en milieu scolaire touchant les enfants « souffre-douleur » Abstract. L’article propose une réflexion...»

«Cognitive Science 30 (2006) 531–553 Copyright © 2006 Cognitive Science Society, Inc. All rights reserved. Memory and Mystery: The Cultural Selection of Minimally Counterintuitive Narratives Ara Norenzayana, Scott Atranb, Jason Faulknera, Mark Schallera aDepartment of Psychology, University of British Columbia bInstitut Jean Nicod, CNRS, Paris and Institute for Social Research, The University of Michigan, Ann Arbor Received 12 January 2005; received in revised form 19 October 2005; accepted...»

«YOU’RE a Grand Officer Head 2 Toe Intro As a Grand Officer YOU are expected to present yourself in a professional way at every event that you attend. This is not only important in Rainbow, but also in the professional business world. Keep that in mind!! Our Grand Officer dress code is to be used at all Rainbow functions. If you are not following the dress code, YOU will not be treated as a Grand Officer. The Mother Advisor and Grand Deputies are instructed NOT to escort you, but to introduce...»

«Political Psychology, Vol. 31, No. 4, 2010 doi: 10.1111/j.1467-9221.2010.00768.x The Behavioral Logic of Collective Action: Partisans Cooperate and Punish More Than Nonpartisansp ops_768 595.616 Oleg Smirnov Stony Brook University Christopher T. Dawes University of California, San Diego James H. Fowler University of California, San Diego Tim Johnson Stanford University Richard McElreath University of California, Davis Laboratory experiments indicate that many people willingly contribute to...»

<<  HOME   |    CONTACTS
2016 www.dissertation.xlibx.info - Dissertations, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.